Log in
Enquire now
‌

US Patent 9987340 Compositions and methods of using chondroitinase ABCI mutants

Patent 9987340 was granted and assigned to Acorda Therapeutics, Inc. on June, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc.
Current Assignee
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9987340
Patent Inventor Names
Jennifer Iaci0
Andrea Vecchione0
Anthony O. Caggiano0
Date of Patent
June 5, 2018
Patent Application Number
15230040
Date Filed
August 5, 2016
Patent Primary Examiner
‌
Ganapathirama Raghu
Patent abstract

The present disclosure relates to protein and nucleic acid mutants of chondroitinase ABCI. Such nucleic acid mutants encode for chondroitinase ABCI mutant enzymes exhibiting altered chondroitin lyase activity or increased resistance to inactivation from stressors including UV light or heat. Methods of using such nucleic acid mutants encoding chondroitinase ABCI mutant enzymes is also provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9987340 Compositions and methods of using chondroitinase ABCI mutants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.